Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
400 participants
INTERVENTIONAL
2020-03-06
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HoLEP
Conventional laser
Moses technology
Using Holmium laser with Moses technology or conventional one
m-HoLEP
Moses technology
Moses technology
Using Holmium laser with Moses technology or conventional one
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moses technology
Using Holmium laser with Moses technology or conventional one
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acceptance to participate in the study.
Exclusion Criteria
* Previous prostate surgery
* Neurogenic bladder
* Bladder tumor
* Neurological disease with repercussion in the lower urinary tract.
* Severe psychiatric illness
* Inability of the patient to consent
18 Years
100 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitari Vall d'Hebron Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
José Placer Santos, PhD
Role: PRINCIPAL_INVESTIGATOR
Vall d'Hebrón University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vall d'Hebron University Hospital
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Adrià Piñero, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR(AG)501/2019
Identifier Type: -
Identifier Source: org_study_id